Biotech Investing BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
Biotech Investing BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
Biotech Investing BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+ in Breast and Prostate Cancer Models
Biotech Investing BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
Biotech Investing BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+ for Breast Cancer
Biotech Investing BriaCell's Bria-OTS+ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
Standard Uranium Retains 100% Unencumbered Ownership of the Sun Dog Project Through Conclusion of Property Option Agreement
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea
